NRIX Earnings

Quarterly EPS
$-0.67
Q3 2024
$-0.75
Q4 2024
$-0.67
Q1 2025
$-0.52
Q2 2025
$-1.03
Q3 2025
$-0.82
Q4 2025
$-0.79
Q1 2026
$-0.81
Q2 2026
Latest Revenue9.0M
Latest Net Income-89535000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.819.0M-89535000-79.5%-55.8%
Q1 2026-$0.796.3M-87174000-66.1%-17.9%
Q4 2025-$0.8213.6M-78221000+2.2%-9.3%
Q3 2025-$1.037.9M-86421000-37.3%-53.7%
Q2 2025-$0.5244.1M-43464000+264.3%+26.8%
Q1 2025-$0.6718.5M-56351000+11.3%+11.8%
Q4 2024-$0.7513.3M-58549000-12.4%+2.6%
Q3 2024-$0.6712.6M-48956000-31.8%+1.5%
Q2 2024-$0.7112.1M-44546000
Q1 2024-$0.7616.6M-41518000
Q4 2023-$0.7715.2M-41956000
Q3 2023-$0.6818.5M-36982000
Nurix Therapeutics (NRIX) — Earnings